valerates has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, K; Imai, H; Matsuhashi, N; Nonaka, K; Okumura, N; Osada, S; Sasaki, Y; Takahashi, T; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yawata, K; Yoshida, K | 1 |
| Alon, R; Cahalon, L; Greenspoon, N; Hardan, I; Hershkoviz, R; Lider, O; Reich, S; Slavin, S; Weiss, L | 1 |
2 other study(ies) available for valerates and Lung Neoplasms
| Article | Year |
|---|---|
A case report on efficacy of Abound™ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer.
Topics: Aged; Antibodies, Monoclonal; Colonic Neoplasms; Dipeptides; ErbB Receptors; Humans; Lung Neoplasms; Male; Panitumumab; Prognosis; Skin Diseases; Valerates | 2014 |
Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic Arg-Gly-Asp mimetics.
Topics: Animals; Cell Adhesion; Dipeptides; Female; Fibronectins; Glycoproteins; Guanidines; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Valerates; Vitronectin | 1993 |